Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06189066 · ClinicalTrials.gov registry record · NA

Long COVID Ultrasound Trial

A NA study of Long COVID, sponsored by SecondWave Systems.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT06189066 is a NA study of Long COVID that has completed, run by SecondWave Systems. The registered enrollment target is 15 participants, below the 2,188-participant average among 50 other Long COVID trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06189066, a NA study of Long COVID, has completed, sponsored by SecondWave Systems.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The research objective is to assess the safety and potential efficacy of spleen ultrasound stimulation as an intervention for Long COVID in a pilot study. Specific Aims include: * Measure Long COVID disease activity before, during and after an 8-week course of spleen-directed daily ultrasound stimulation. * Measure molecular correlates of Long COVID disease activity before, during and after an 8-week course of spleen-directed daily ultrasound stimulation. * Track adverse events throughout the study to assess safety of the ultrasound intervention.

Conditions Studied

Interventions

  • DEVICE Splenic Ultrasound

Study Locations (1)

Minnesota

  • University of Minnesota - Phillips-Wangensteen Building - Minneapolis

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2024-01-03
Est. Completion 2025-07-24
Phase NA

Sponsor

SecondWave Systems

3 total trials

What the Registry Record Tells You About NCT06189066

The ClinicalTrials.gov registry entry for NCT06189066 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,188-participant average among 50 other Long COVID trials with a reported enrollment target (99% lower). The listed sponsor is SecondWave Systems, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Long COVID appearing as the primary indexed condition, and to 1 intervention - of which Splenic Ultrasound is the first listed.

NCT06189066 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06189066 about?

NCT06189066 is a clinical study titled "Long COVID Ultrasound Trial". The research objective is to assess the safety and potential efficacy of spleen ultrasound stimulation as an intervention for Long COVID in a pilot study. Specific Aims include: * Measure Long COVID disease activity before, during and after an 8-week course of spleen-directed daily ultrasound stim...

What is the current status of trial NCT06189066?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2024-01-03. Estimated completion is 2025-07-24.

What conditions does trial NCT06189066 study?

This clinical trial studies the following conditions: Long COVID.

What interventions are being tested in trial NCT06189066?

The interventions under investigation include: Splenic Ultrasound (DEVICE).

Who is sponsoring clinical trial NCT06189066?

This trial is sponsored by SecondWave Systems, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06189066 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Long COVID

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.